Investment Incentives created by the Montreal Protocol and Fda Policy on Albuterol

doi:10.1111/j.1747-1796.2003.tb00244.x

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

The Journal of World Intellectual Property

Volume 6 Issue 6, Pages 807 - 825

Published Online: 1 Nov 2005

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | Full Text: PDF (Size: 1098K) | Related Articles | Citation Tracking

Investment Incentives created by the Montreal Protocol and Fda Policy on Albuterol

Richard P. Rozek* and Emily R. Bishko*

*Senior Vice President and Analyst, respectively, at National Economic Research Associates, Inc. (Nera), Washington, D.C.

Correspondence to For the details of the underlying calculations covered in the text, an Appendix is available from the authors upon request. They may be contacted at: «richard.rozek@nera.com>>, or «emily.bishko@nera.com>>.

GlaxoSmithKline (GSK) provided financial support for the economic research described in this article.

FIRST PAGE OF ARTICLE

DIGITAL OBJECT IDENTIFIER (DOI)

10.1111/j.1747-1796.2003.tb00244.x About DOI

Find other articles like this in Wiley InterScience
Find articles in Wiley InterScience written by any of the authors

Request Reprint Reprint Request

Wiley InterScience is a member of CrossRef.

IT'S TIME TO RENEW

	It’s time to renew your subscription to The Journal of World Intellectual Property.
Click here for 2010 subscription rates and to renew securely online.